The immune response in atherosclerosis: a double-edged sword (Q36508676)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 16 June 2006

Language	Label	Description	Also known as
English	The immune response in atherosclerosis: a double-edged sword	scientific article published on 16 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

The immune response in atherosclerosis: a double-edged sword (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

2

object named as

Peter Libby

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

Göran K Hansson

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

16 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Nature Reviews Immunology

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

508-519

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

S-100 positive cells in human arterial intima and in atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

The combined role of P- and E-selectins in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Scavenger receptors in innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

The macrophage scavenger receptor type A directs modified proteins to antigen presentation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Innate immune recognition

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Unstable atherosclerotic plaques contain T-cells that respond to Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

CD1d-dependent activation of NKT cells aggravates atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Natural killer T cells accelerate atherogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Variation in susceptibility to atherosclerosis among inbred strains of mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Inhibition of endothelial cell proliferation by gamma-interferon

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cachectin and tumour necrosis factor as two sides of the same biological coin

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Requirement for CD154 in the progression of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Protective Role of Interleukin-10 in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Natural regulatory T cells control the development of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Stabilization of atherosclerotic plaques: new mechanisms and clinical targets

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Atherosclerosis and proteinase activation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40–CD40L signalling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Overcoming restenosis with sirolimus: from alphabet soup to clinical reality

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Metaanalysis of statins and survival in de novo cardiac transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Coxibs and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

31 March 2020

T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1

1 reference

https://api.crossref.org/works/10.1038%2FNRI1882

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NRI1882

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36508676&oldid=1636438344"